Lead Product(s): Undisclosed
Therapeutic Area: Infections and Infectious Diseases
Highest Development Status: Undisclosed Product Type: Vaccine
Partner/Sponsor/Collaborator: Vingroup Innovation Foundation
Deal Size: $0.3 million Upfront Cash: Undisclosed
Deal Type: Funding February 21, 2020
With this funding, Vabiotech will be developing vaccines against the novel coronavirus (Covid-19) on growing medium of Baculoviruses at laboratory scale led by Dr. Do Tuan Dat.